8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 16, 2026·SEC
Material company update
Feb 4, 2026·SEC
LifeVantage Corporation(LFVN)Earnings, Financials & Key Ratios
LFVN•NASDAQ
$6.24
8.2× P/E·Price updated Jul 7, 2026
AboutLifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.Show more
- Revenue$229M+14.2%
- EBITDA$15M+94.0%
- Net Income$10M+233.8%
- EPS (Diluted)0.76+230.4%
- Gross Margin80.37%+1.4%
- EBITDA Margin6.72%+70.0%
- Operating Margin5.34%+146.7%
- Net Margin4.29%+192.4%
- ROE32.34%+233.9%
LFVN Price & Volume
LifeVantage Corporation (LFVN) stock price & volume — 10-year historical chart
Loading chart...
Operational Pivot Strains Revenue and Margin Stability
Investment Thesis • Updated 2026Q3
VerdictNegative
Growth:Decelerating
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Distributor Network Churn
Key Thesis Takeaways
- LifeVantage faces a challenging transition as its LV360 operational framework coincides with a 25.2% year-over-year revenue contraction in 2026Q3.
- While the company maintains a conservative debt-to-equity ratio of 0.31, the persistent accumulation of $103.7 million in negative retained earnings suggests long-term structural challenges to shareholder equity.
- Investors should monitor whether the current 3.8% operating margin can scale effectively or if the reliance on a high-commission direct-selling model will continue to erode profitability.
Verdict Logic
the company's reliance on a high-commission model and the 25.2% revenue decline in 2026Q3 suggest that the current 8.71 P/E ratio may not adequately reflect the risks of the ongoing organizational pivot.
LFVN Growth Metrics
LifeVantage Corporation (LFVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.85%
5 Years-0.38%
3 Years3.46%
TTM-12.15%
Profit CAGR
10 Years3.45%
5 Years-3.22%
3 Years46.48%
TTM-37.14%
EPS CAGR
10 Years4.49%
5 Years-0.77%
3 Years46.85%
TTM-34.54%
Return on Capital
10 Years32.29%
5 Years20.95%
3 Years16.35%
Last Year29.49%
LFVN Recent Earnings
LifeVantage Corporation (LFVN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.12-25.0%
$0.16
Rev
$44M-8.5%
$48M
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$0.15-21.1%
$0.19
Rev
$49M-10.1%
$54M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.18+5.9%
$0.17
Rev
$58M+7.4%
$54M
Q4 2025
Sep 4, 2025Metric
Actual
Est
EPS
$0.17+0.0%
$0.17
Rev
$55M-4.9%
$58M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.12vs $0.16-25.0% | $44Mvs $48M-8.5% |
| Q1 2026 | Feb 4, 2026 | $0.15vs $0.19-21.1% | $49Mvs $54M-10.1% |
| Q4 2025 | Nov 4, 2025 | $0.18vs $0.17+5.9% | $58Mvs $54M+7.4% |
| Q4 2025 | Sep 4, 2025 | $0.17vs $0.17+0.0% | $55Mvs $58M-4.9% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for LifeVantage Corporation (LFVN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $6.24 | $78.72M | 8.21 | 14.17% | 4.29% | 32.34% | 2.55% | |
| $21.75 | $382.47M | 20.52 | 5.67% | 4.06% | 12.08% | — | |
| $1.82 | $20.31M | -23.73 | -7.42% | -3.03% | -4.88% | — | |
| $16.27 | $934.64M | 201.61 | 78.27% | 5.53% | 23.85% | — | |
| $13.14 | $1.36B | 5.97 | 0.89% | 4.67% | — | — | |
| $22.38 | $413.2M | 38.59 | 8.28% | 0.96% | 1.51% | — |
Compare LFVN vs Peers
LifeVantage Corporation (LFVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFVN SEC Filings & Documents
LifeVantage Corporation (LFVN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when LFVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LFVN Frequently Asked Questions
LifeVantage Corporation (LFVN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is LifeVantage Corporation's revenue?
LifeVantage Corporation (LFVN) reported $195.3M in revenue for fiscal year 2025.
How fast is LifeVantage Corporation growing?
LifeVantage Corporation (LFVN) grew revenue by 14.2% over the past year. This is steady growth.
Is LFVN profitable?
Yes, LifeVantage Corporation (LFVN) is profitable, generating $5.8M in net income for fiscal year 2025 (4.3% net margin).
Dividend & Returns
Does LFVN pay dividends?
Yes, LifeVantage Corporation (LFVN) pays a dividend with a yield of 2.55%. This makes it attractive for income-focused investors.
What is LFVN's return on equity?
LifeVantage Corporation (LFVN) has a return on equity (ROE) of 32.3%. This is excellent, indicating efficient use of shareholder capital.
What is LifeVantage Corporation's free cash flow?
LifeVantage Corporation (LFVN) generated $3.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.